当前位置: 首页 >> 检索结果
81. An X chromosome-wide meta-analysis based on Japanese cohorts revealed that non-autosomal variations are associated with serum urate.
作者: Masahiro Nakatochi.;Yu Toyoda.;Masahiro Kanai.;Akiyoshi Nakayama.;Yusuke Kawamura.;Asahi Hishida.;Haruo Mikami.;Keitaro Matsuo.;Toshiro Takezaki.;Yukihide Momozawa.;The Biobank Japan Project.;Yoichiro Kamatani.;Sahoko Ichihara.;Nariyoshi Shinomiya.;Mitsuhiro Yokota.;Kenji Wakai.;Yukinori Okada.;Hirotaka Matsuo.; .
来源: Rheumatology (Oxford). 2021年60卷9期4430-4432页 82. A systematic review and meta-analysis of the incidence rate of Takayasu arteritis.
作者: Megan Rutter.;Jonathan Bowley.;Peter C Lanyon.;Matthew J Grainge.;Fiona A Pearce.
来源: Rheumatology (Oxford). 2021年60卷11期4982-4990页
Takayasu arteritis (TAK) is a rare autoimmune rheumatic disease causing large-vessel vasculitis. Onset is typically between the ages of 20 and 30 years. It is associated with substantial morbidity and mortality, notably due to its effects on the cardiovascular system. It has a poorly understood global epidemiology. Our objective was to systematically review the available evidence in order to calculate the incidence rate of TAK.
83. Mortality in patients with primary Sjögren's syndrome: a systematic review and meta-analysis.
作者: Hong Huang.;Wenhui Xie.;Yan Geng.;Yong Fan.;Zhuoli Zhang.
来源: Rheumatology (Oxford). 2021年60卷9期4029-4038页
It remains debated whether patients with primary Sjögren's syndrome (pSS) are at greater risk of mortality. We aimed to determine the magnitude of all-cause mortality risk in patients with pSS compared with the general population through a systematic review and meta-analysis.
84. Maternal and neonatal outcomes in pregnant women with psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
作者: Wenhui Xie.;Hong Huang.;Lanlan Ji.;Zhuoli Zhang.
来源: Rheumatology (Oxford). 2021年60卷9期4018-4028页
Psoriasis and PsA are inflammatory diseases that affect women in their reproductive years. We aimed to investigate whether maternal psoriasis and PsA are associated with adverse pregnancy outcomes.
85. Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
作者: Philip J Mease.;Iain B McInnes.;Lai-Shan Tam.;Kiefer Eaton.;Steve Peterson.;Agata Schubert.;Soumya D Chakravarty.;Anna Parackal.;Chetan S Karyekar.;Sandhya Nair.;Wolf-Henning Boehncke.;Christopher Ritchlin.
来源: Rheumatology (Oxford). 2021年60卷5期2109-2121页
The efficacy of the novel interleukin (IL)-23p19 inhibitor guselkumab for psoriatic arthritis (PsA) has recently been demonstrated in two phase 3 trials (DISCOVER-1 & -2) but has not been evaluated vs other targeted therapies for PsA. The objective was to compare guselkumab to targeted therapies for PsA for safety and joint and skin efficacy through network meta-analysis (NMA).
86. Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study.
作者: Rishi J Desai.;Ajinkya Pawar.;Farzin Khosrow-Khavar.;Michael E Weinblatt.;Seoyoung C Kim.
来源: Rheumatology (Oxford). 2021年61卷1期121-130页
To evaluate the risk of venous thromboembolism (VTE) with tofacitinib compared with TNFis in patients with RA.
87. The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis.
作者: Sara Monti.;Paolo Delvino.;Mattia Riboli.;Chiara Rebuffi.;Blerina Xoxi.;Annalisa De Silvestri.;Carlomaurizio Montecucco.
来源: Rheumatology (Oxford). 2021年60卷8期3553-3564页
To assess available evidence from randomized controlled trials (RCTs) and observational studies including a control group regarding the role of trimethoprim/sulfametoxazole (TMP/SMX) in reducing the relapse rate in patients with granulomatosis with polyangiitis (GPA) and the risk of infections in patients with ANCA-associated vasculitis (AAV).
88. Prevalence and risk factors of relapse in patients with ANCA-associated vasculitis receiving cyclophosphamide induction: a systematic review and meta-analysis of large observational studies.
作者: Peng He.;Jin-Ping Hu.;Xiu-Juan Tian.;Li-Jie He.;Shi-Ren Sun.;Chen Huang.
来源: Rheumatology (Oxford). 2021年60卷3期1067-1079页
Clinical relapses are common in patients with ANCA-associated vasculitis (AAV). The aim of this systematic review was to estimate time-point prevalence and risk factors of relapse.
89. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis.
作者: Majd Bairkdar.;Marios Rossides.;Helga Westerlind.;Roger Hesselstrand.;Elizabeth V Arkema.;Marie Holmqvist.
来源: Rheumatology (Oxford). 2021年60卷7期3121-3133页
We aimed to conduct a systematic review and meta-analysis on the incidence and prevalence of SSc covering the entire literature.
90. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.
作者: Alexander G S Oldroyd.;Andrew B Allard.;Jeffrey P Callen.;Hector Chinoy.;Lorinda Chung.;David Fiorentino.;Michael D George.;Patrick Gordon.;Kate Kolstad.;Drew J B Kurtzman.;Pedro M Machado.;Neil J McHugh.;Anna Postolova.;Albert Selva-O'Callaghan.;Jens Schmidt.;Sarah Tansley.;Ruth Ann Vleugels.;Victoria P Werth.;Rohit Aggarwal.
来源: Rheumatology (Oxford). 2021年60卷6期2615-2628页
To identify clinical factors associated with cancer risk in the idiopathic inflammatory myopathies (IIMs) and to systematically review the existing evidence related to cancer screening.
91. Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis.
作者: Luke Furtado O'Mahony.;Arnav Srivastava.;Puja Mehta.;Coziana Ciurtin.
来源: Rheumatology (Oxford). 2021年60卷6期2602-2614页
The aetiology of primary chronic pain syndromes (CPS) is highly disputed. We performed a systematic review and meta-analysis aiming to assess differences in circulating cytokine levels in patients with diffuse CPS (fibromyalgia) vs healthy controls (HC).
92. Low-dose glucocorticoids should be withdrawn or continued in systemic lupus erythematosus? A systematic review and meta-analysis on risk of flare and damage accrual.
To assess the risk of flare and damage accrual after discontinuation of low-dose glucocorticoids (GCs) in SLE.
93. Effects of physical activity on vascular function in autoimmune rheumatic diseases: a systematic review and meta-analysis.
作者: Tiago Peçanha.;Daniel J Bannell.;Sofia Mendes Sieczkowska.;Nicola Goodson.;Hamilton Roschel.;Victoria S Sprung.;David A Low.
来源: Rheumatology (Oxford). 2021年60卷7期3107-3120页
To summarize existing evidence and quantify the effects of physical activity on vascular function and structure in autoimmune rheumatic diseases (ARDs).
94. Efficacy and safety of multiple intra-articular corticosteroid injections for osteoarthritis-a systematic review and meta-analysis of randomized controlled trials and observational studies.
作者: Shazeen Ayub.;Jaspreet Kaur.;Michelle Hui.;Shima Espahbodi.;Michelle Hall.;Michael Doherty.;Weiya Zhang.
来源: Rheumatology (Oxford). 2021年60卷4期1629-1639页
To investigate the efficacy and safety of multiple intra-articular corticosteroid (IACS) injections for the treatment of OA.
95. Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis.
作者: Sizheng Steven Zhao.;Bradley Pittam.;Nicholas L Harrison.;Ashar E Ahmed.;Nicola J Goodson.;David M Hughes.
来源: Rheumatology (Oxford). 2021年60卷4期1620-1628页
Delay to diagnosis in axial SpA (axSpA) is longer than in many other rheumatic diseases. Prolonged delay is associate with poorer outcomes, including functional impairment and quality of life. Our aims were to describe global variation in delay to diagnosis, factors associated with delay, and delay compared with PsA.
96. CD34+CD133+CD309+ circulating angiogenic cell level is reduced but positively related to hydroxychloroquine use in SLE patients-a case-control study and meta-regression analysis.
作者: Jinghui Huang.;Nien Yee Kow.;Hui Yin Lee.;Anna-Marie Fairhurst.;Anselm Mak.
来源: Rheumatology (Oxford). 2021年60卷8期3936-3944页
To identify and quantify the level of CD34+CD133+CD309+ circulating angiogenic cells (CAC) and explore factors associated with the level of CAC in patients with SLE.
97. Socioeconomic status and occurrence of chronic pain: a meta-analysis.
作者: Jesús Prego-Domínguez.;Zahra Khazaeipour.;Narmeen Mallah.;Bahi Takkouche.
来源: Rheumatology (Oxford). 2021年60卷3期1091-1105页
To examine the association between socioeconomic status (SES) and the occurrence of chronic pain, defined as pain that persists or recurs for >3 months.
98. Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis.
作者: Ilaria Maccora.;Eleonora Fusco.;Edoardo Marrani.;Athimalaipet V Ramanan.;Gabriele Simonini.
来源: Rheumatology (Oxford). 2021年60卷2期568-587页
To summarize evidence regarding efficacy of anti-TNFα in childhood chronic uveitis, refractory to common DMARDs.
99. Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.
作者: Rudra P Goswami.;Animesh Ray.;Moumita Chatterjee.;Arindam Mukherjee.;Geetabali Sircar.;Parasar Ghosh.
来源: Rheumatology (Oxford). 2021年60卷2期557-567页
To assess the effect of rituximab (RTX) on the lung function parameters in SSc interstitial lung disease (SSc-ILD) patients.
100. Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis.
作者: M Guillouard.;N Authier.;B Pereira.;M Soubrier.;S Mathieu.
来源: Rheumatology (Oxford). 2021年60卷2期549-556页
Despite classic analgesic or effective treatments in rheumatic diseases, such as synthetic DMARDs in RA, patients remain in pain and often turn to non-prescribed pharmacological alternatives, such as cannabis self-therapeutic use. However, this medical use of cannabis has not been thoroughly studied.
|